632 related articles for article (PubMed ID: 32497621)
21. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
Cheng C; Qin Y; Zhi Q; Wang J; Qin C
Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
[TBL] [Abstract][Full Text] [Related]
22. LncRNA TMPO-AS1 promotes LCN2 transcriptional activity and exerts oncogenic functions in ovarian cancer.
Zhao H; Ding F; Zheng G
FASEB J; 2020 Sep; 34(9):11382-11394. PubMed ID: 32692467
[TBL] [Abstract][Full Text] [Related]
23. LncRNA TMPO-AS1 facilitates the proliferation and metastasis of NSCLC cells by up-regulating ERBB2 via sponging miR-204-3p.
Yu X; Lin Q; Liu F; Yang F; Mao J; Chen X
Int J Immunopathol Pharmacol; 2020; 34():2058738420958947. PubMed ID: 32969763
[TBL] [Abstract][Full Text] [Related]
24. Silencing of Long Non-coding RNA TTN-AS1 Inhibits Hepatocellular Carcinoma Progression by the MicroRNA-134/ITGB1 Axis.
Huang Y; Chu P; Bao G
Dig Dis Sci; 2021 Nov; 66(11):3916-3928. PubMed ID: 33387127
[TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis.
Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C
J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764
[TBL] [Abstract][Full Text] [Related]
26. Long noncoding RNA TMPO-AS1 promotes lung adenocarcinoma progression and is negatively regulated by miR-383-5p.
Mu X; Wu H; Liu J; Hu X; Wu H; Chen L; Liu W; Luo S; Zhao Y
Biomed Pharmacother; 2020 May; 125():109989. PubMed ID: 32062549
[TBL] [Abstract][Full Text] [Related]
27. Long noncoding RNA WDFY3-AS2 suppresses tumor progression by acting as a competing endogenous RNA of microRNA-18a in ovarian cancer.
Li W; Ma S; Bai X; Pan W; Ai L; Tan W
J Cell Physiol; 2020 Feb; 235(2):1141-1154. PubMed ID: 31347170
[TBL] [Abstract][Full Text] [Related]
28. LncRNA MAFG-AS1 promotes the malignant phenotype of ovarian cancer by upregulating NFKB1-dependent IGF1.
Bai Y; Ren C; Wang B; Xue J; Li F; Liu J; Yang L
Cancer Gene Ther; 2022 Mar; 29(3-4):277-291. PubMed ID: 34035482
[TBL] [Abstract][Full Text] [Related]
29. Long noncoding RNA TMPO-AS1 promotes progression of non-small cell lung cancer through regulating its natural antisense transcript TMPO.
Qin Z; Zheng X; Fang Y
Biochem Biophys Res Commun; 2019 Aug; 516(2):486-493. PubMed ID: 31230752
[TBL] [Abstract][Full Text] [Related]
30. Roles of the SNHG7/microRNA‑9‑5p/DPP4 ceRNA network in the growth and
Chen W; Yu J; Xie R; Zhou T; Xiong C; Zhang S; Zhong M
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649840
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA HNF1A-AS1 mediated repression of miR-34a/SIRT1/p53 feedback loop promotes the metastatic progression of colon cancer by functioning as a competing endogenous RNA.
Fang C; Qiu S; Sun F; Li W; Wang Z; Yue B; Wu X; Yan D
Cancer Lett; 2017 Dec; 410():50-62. PubMed ID: 28943452
[TBL] [Abstract][Full Text] [Related]
32. LncRNA RUSC1-AS1 promotes osteosarcoma progression through regulating the miR-340-5p and PI3K/AKT pathway.
Tong CJ; Deng QC; Ou DJ; Long X; Liu H; Huang K
Aging (Albany NY); 2021 May; 13(16):20116-20130. PubMed ID: 34048366
[TBL] [Abstract][Full Text] [Related]
33. LncRNA ASB16-AS1 accelerates cellular process and chemoresistance of ovarian cancer cells by regulating GOLM1 expression via targeting miR-3918.
Fan Y; Wang L; Han X; Ma H; Zhang N; She L
Biochem Biophys Res Commun; 2023 Oct; 675():1-9. PubMed ID: 37429067
[TBL] [Abstract][Full Text] [Related]
34. Sanguinarine inhibits epithelial ovarian cancer development via regulating long non-coding RNA CASC2-EIF4A3 axis and/or inhibiting NF-κB signaling or PI3K/AKT/mTOR pathway.
Zhang S; Leng T; Zhang Q; Zhao Q; Nie X; Yang L
Biomed Pharmacother; 2018 Jun; 102():302-308. PubMed ID: 29571014
[TBL] [Abstract][Full Text] [Related]
35. STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway.
Wen J; Wang H; Dong T; Gan P; Fang H; Wu S; Li J; Zhang Y; Du R; Zhu Q
Cell Prolif; 2019 Mar; 52(2):e12569. PubMed ID: 30657221
[TBL] [Abstract][Full Text] [Related]
36. Roles of DANCR/microRNA-518a-3p/MDMA ceRNA network in the growth and malignant behaviors of colon cancer cells.
Sun Y; Cao B; Zhou J
BMC Cancer; 2020 May; 20(1):434. PubMed ID: 32423468
[TBL] [Abstract][Full Text] [Related]
37. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
[TBL] [Abstract][Full Text] [Related]
38. Silencing UNC5B antisense lncRNA 1 represses growth and metastasis of human Colon cancer cells via raising miR-622.
Zhang Y; Li Z; Lan Z
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):60-67. PubMed ID: 31852293
[No Abstract] [Full Text] [Related]
39. Long non-coding RNA TNK2 AS1/microRNA-125a-5p axis promotes tumor growth and modulated phosphatidylinositol 3 kinase/AKT pathway.
Guo L; Ma H; Kong Y; Leng G; Liu G; Zhang Y
J Gastroenterol Hepatol; 2022 Jan; 37(1):124-133. PubMed ID: 34494305
[TBL] [Abstract][Full Text] [Related]
40. Non-coding RNA LOXL1-AS1 exhibits oncogenic activity in ovarian cancer via regulation of miR-18b-5p/VMA21 axis.
Xue F; Xu YH; Shen CC; Qin ZL; Zhou HB
Biomed Pharmacother; 2020 May; 125():109568. PubMed ID: 32058209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
